A haematoma is a localized collection of extravasated blood trapped outside the vascular system following vessel rupture, typically from trauma. Unlike ecchymosis (simple bruising), haematoma represents significant vascular injury with measurable three-dimensional blood pooling within tissue compartments. The presence and size of haematoma fundamentally alter healing timelines because blood must be enzymatically broken down and resorbed before tissue architecture can be restored.
Imagine a water main breaks under a city street. The escaping water doesn't just wet the surfaceβit pools in the soil layers below, creating an underground reservoir that pressurizes the surrounding earth. This pocket of water must be pumped out before road crews can assess damage and rebuild the street layers. The city sends in emergency response teams (platelets) to seal the broken pipe with temporary patches, then sanitation workers (neutrophils) to clear debris, followed by specialized crews (macrophages) who pump out the pooled water and cart away contaminated soil. The bigger the underground reservoir, the longer it takes to emptyβand until it's gone, construction crews can't rebuild the road properly. If the cleanup is rushed or the pool isn't fully drained, the soil becomes unstable and the "repair" hardens into weak, uneven patches (scar tissue). In muscle tissue, that blood pool is your haematoma, and every milliliter of trapped blood adds days to the repair timeline because your cellular work crews can only process blood at a fixed rate.
Haematoma formation and resolution follows a stereotyped immunometabolic cascade:
Phase 1: Vascular Rupture and Clot Formation (0-6 hours)
- Trauma ruptures capillaries, arterioles, or venules β blood extravasates into interstitial space
- Platelets aggregate at vessel breach sites β release of von Willebrand factor, thromboxane A2, ADP
- Platelets β degranulation releasing VEGF, PDGF, TGF-beta β chemotaxis of inflammatory cells
- Coagulation cascade activation: Tissue Factor β Factor VII β Factor X β thrombin β fibrinogen β fibrin meshwork
- DAMPs released from damaged cells: HMGB1, heat shock proteins, mitochondrial DNA β TLR4 activation on resident macrophages
Phase 2: Inflammatory Infiltration (6-72 hours)
- Neutrophils recruited via CXCL1, IL-8 gradients β peak at 24 hours
- Neutrophils β phagocytosis of cellular debris + NETosis (chromatin traps) to contain damage
- Macrophages recruited via MCP-1 (CCL2) β M1 macrophages predominate initially
- Red blood cell breakdown begins: hemoglobin β heme β biliverdin β bilirubin (yellow-green discoloration)
- Iron liberated from heme β sequestered by ferritin or exported via ferroportin to prevent Reactive Oxygen Species generation
- Mechanical pressure from pooled blood β compression of surrounding tissue β local hypoxia β HIF-1 activation
Phase 3: Haematoma Resorption (3-21 days)
Phase 4: Complication Risk Windows
- Days 7-14: Risk of myositis ossificans (heterotopic bone formation) if immobilized or re-injured
- Calcification occurs via: persistent inflammation β BMP-2 release β osteoblast differentiation in haematoma
- Compartment syndrome risk if haematoma volume exceeds fascial compartment compliance
graph TD
A[Vessel Rupture] --> B[Platelet Aggregation]
B --> C[Fibrin Clot Formation]
B --> D[DAMP Release]
D --> E[Neutrophil Recruitment 24h]
D --> F[M1 Macrophage Recruitment 48h]
C --> G[Haematoma Formation]
G --> H[RBC Breakdown]
H --> I["Hemoglobin β Bilirubin"]
H --> J[Free Iron Release]
J --> K{Iron Management}
K -->|Success| L[Ferritin Storage]
K -->|Failure| M[Oxidative Stress]
F --> N["M1 β M2 Switch Day 3-5"]
N --> O[Efferocytosis]
N --> P[MMP Activation]
P --> Q[Fibrin Degradation]
Q --> R[SPM Synthesis]
R --> S[Resolution Complete 2-3 weeks]
G --> T{Size >25mm?}
T -->|Yes| U["Extended Timeline >3 weeks"]
T -->|Yes| V[Complication Risk]
V --> W[Myositis Ossificans]
V --> X[Compartment Syndrome]
Diagnostic and Prognostic Value
Haematoma visible on imaging (ultrasound, MRI) automatically extends minimum healing time to 2-3 weeks minimum regardless of patient age or fitness because blood vessel regeneration is rate-limiting. This is a critical point for athlete return-to-sport decisions: muscle fibers can regenerate in 7-10 days, but vessels take 14-21 days. Returning to loading before vascular healing completes β re-bleeding and reset of inflammatory clock.
Size-Based Stratification (Leo Pruimboom protocol):
- <10mm diameter: Minor haematoma, 2-week healing minimum
- 10-25mm diameter: Moderate haematoma, 3-week healing minimum, controlled mobilization essential
-
25mm diameter: Major haematoma, 4-6 week healing minimum, high complication risk
- Haematoma volume correlates logarithmically with healing time (doubling size = +7-10 days)
Imaging Characteristics:
- Ultrasound: Hypoechoic (dark) area with irregular borders, becomes more organized over days 3-7
- MRI: Hyperintense (bright) on T2-weighted images, central hypointensity on T1 represents deoxygenated blood
- Ultrasound elastography: Can quantify haematoma stiffness as it organizes
Selfish Immune System Connection
Haematoma clearance is metabolically expensiveβeach gram of clotted blood requires ~50 kcal to break down and resorb via macrophage phagocytosis. The selfish immune system will prioritize haematoma resolution over tissue repair if caloric availability is marginal, explaining delayed healing in undernourished athletes or chronic dieters. This links to Metamodel 1 (energy distribution): inadequate protein intake (especially glycine, proline, lysine for collagen synthesis) during haematoma phase β fibrotic repair dominates.
Evolutionary Mismatch
Modern complete immobilization of injuries conflicts with ancestral movement patterns that facilitated haematoma drainage via muscle pump action. Hunter-gatherers with muscle injuries would have continued low-grade movement (foraging, walking), creating gentle pressure gradients that assist lymphatic clearance of haematoma breakdown products. Current "RICE" protocols (complete rest) may paradoxically extend haematoma duration.
Intervention Implications
- AVOID NSAIDs: NSAIDs inhibit COX-2 β blocks prostaglandin synthesis β impairs M1-to-M2 macrophage phenotype switching β delays haematoma resolution by 30-50%
- Early controlled mobilization: Gentle muscle contraction (20-30% max voluntary contraction) from day 3-5 β creates pressure gradients β accelerates lymphatic drainage
- Compression therapy: External compression (20-30 mmHg) β reduces haematoma expansion in first 48 hours β smaller final volume
- SPM supplementation: Omega-3 fatty acids (EPA/DHA 2-4g/day) β substrate for resolvins and maresins β accelerates macrophage-mediated clearance
- Avoid heat therapy in first 72h: Vasodilation β increased bleeding β larger haematoma volume
- Monitor for myositis ossificans: Any palpable firmness after day 10 warrants ultrasound reassessment
Critical Clinical Questions (from Leo's protocol):
- Was injury from overstretching (better prognosis) or high-velocity/explosive contraction (worse prognosis)?
- High-velocity injuries β greater vessel shearing β larger haematoma β higher myositis ossificans risk
- Patient on anticoagulation? (warfarin, DOACs, aspirin >100mg/day) β haematoma expansion risk
- Haematoma >25mm diameter = automatic 4-week minimum healing timeline regardless of other factors
- Each 10mm increase in haematoma diameter adds approximately 7-10 days to full healing
- Visible haematoma on ultrasound appears as hypoechoic (dark, anechoic) region within muscle architecture
- MRI T2 hyperintensity indicates edema + blood; bright signal persists 10-14 days post-injury
- Hemoglobin breakdown: Hgb β heme β biliverdin (green) β bilirubin (yellow) over 7-10 days
- Iron from hemoglobin can generate hydroxyl radicals (Β·OH) if not properly sequestered by ferritin
- NSAIDs delay haematoma resolution by 30-50% via impaired macrophage function (avoid first 2 weeks)
- Myositis ossificans develops in 9-17% of large muscle haematomas if inadequately managed
- Risk factors for slow resolution: >40 years age, diabetes, smoking, inadequate protein intake, concurrent NSAID use
- Complete immobilization paradoxically slows haematoma drainage vs controlled early mobilization
- Haematoma resorption rate: approximately 0.5-1.0 mL per day via macrophage efferocytosis
- Blood contains tissue factor and thrombin β creates scaffold for potential calcification if inflammation persists
- Compartment syndrome risk if haematoma exceeds 20% of muscle compartment volume
- muscle injury β haematoma presence indicates grade 2-3 muscle tear with vascular disruption; size determines prognosis
- wound healing β haematoma must be cleared before proliferative phase can begin; delays collagen deposition
- inflammation β haematoma serves as persistent inflammatory stimulus via DAMP release and iron-mediated oxidative stress
- platelets β form initial hemostatic plug at vessel breach; release growth factors (PDGF, VEGF, TGF-Ξ²) that recruit inflammatory cells
- fibrin β creates three-dimensional meshwork that stabilizes haematoma; must be degraded by MMPs before resolution
- neutrophils β first responders (peak 24h) that clear cellular debris via phagocytosis and NETosis within haematoma
- macrophages β essential for haematoma resorption; M1 phenotype clears debris, M2 phenotype performs erythrophagocytosis and promotes resolution
- M1 macrophages β predominate days 1-3; pro-inflammatory phenotype initiates haematoma breakdown
- M2 macrophages β predominate after day 3; express CD163 to clear hemoglobin; synthesize SPMs to accelerate resolution
- DAMPs β released from damaged muscle cells within haematoma; activate TLR4 on macrophages to sustain inflammation
- iron β liberated from hemoglobin breakdown; must be sequestered by ferritin or causes Fenton reaction (FeΒ²βΊ + HβOβ β Β·OH)
- Reactive Oxygen Species β generated if free iron from haematoma not properly managed; damages surrounding healthy tissue
- Matrix metalloproteinases (MMPs) β MMP-2 and MMP-9 degrade fibrin clot to allow haematoma resorption; upregulated by M2 macrophages
- Specialized pro-resolving mediators (SPMs) β resolvins, maresins, lipoxins synthesized from omega-3 FAs; accelerate macrophage-mediated haematoma clearance
- Resolvin D-series β RvD1, RvD2 synthesized from DHA; enhance efferocytosis and reduce neutrophil infiltration in haematoma
- Lipoxins β endogenous "stop signals" for inflammation; promote M1-to-M2 switch in haematoma-associated macrophages
- NSAIDs β inhibit COX-2 β impair prostaglandin synthesis β delay M1-to-M2 macrophage switch β prolong haematoma presence by weeks
- MRI β T2-weighted images show haematoma as hyperintense signal; size correlates with healing timeline
- ultrasound β real-time assessment of haematoma size and organization; hypoechoic area within muscle belly
- edema β surrounds haematoma due to vascular permeability and inflammation; appears as hyperintense rim on MRI
- scar tissue β forms if haematoma resolution incomplete; persistent fibrin + myofibroblast activation β fibrosis
- myositis ossificans β heterotopic bone formation within organizing haematoma; occurs 7-21 days post-injury if inflammation unresolved
- blood vessels β regeneration of damaged vessels is rate-limiting step; takes 14-21 days regardless of muscle fiber healing speed
- VEGF β released by platelets and hypoxic tissue; drives neovascularization within haematoma during resolution phase
- HIF-1 β activated by mechanical compression and hypoxia within haematoma; upregulates VEGF and glycolytic enzymes
- collagen β cannot be properly deposited until haematoma resorbed; premature loading β collagen disorganization and fibrosis
- Fibroblasts β infiltrate haematoma during organization phase; lay down collagen matrix for scar formation if resolution incomplete
- Omega-3 fatty acids β EPA and DHA are substrates for SPM synthesis; supplementation accelerates haematoma resolution
- TGF-beta β released by platelets and macrophages; drives fibroblast activation and collagen synthesis; excess leads to fibrosis
- compartment syndrome β acute complication when haematoma volume exceeds fascial compartment compliance; surgical emergency
- Cold therapy β initial vasoconstriction reduces haematoma expansion in first 48 hours; overuse may delay immune cell infiltration
- heat therapy β contraindicated in first 72 hours; vasodilation increases bleeding and haematoma size
- Metamodel 1 β haematoma clearance is energetically expensive; inadequate nutrition delays resolution and favors fibrotic repair
- Module 5 (Connective Tissue and Wound Healing)